JOHN M CAPEK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN M CAPEK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN M CAPEK. JOHN M CAPEK is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT).
Latest Insider Trading Transactions of JOHN M CAPEK
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.86 | 400 | 18,344 | 226,945 | 227.3 K to 226.9 K (-0.18 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.85 | 2,200 | 100,870 | 227,345 | 229.5 K to 227.3 K (-0.96 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.85 | 300 | 13,754 | 229,545 | 229.8 K to 229.5 K (-0.13 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.84 | 100 | 4,584 | 229,845 | 229.9 K to 229.8 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.84 | 200 | 9,167 | 229,945 | 230.1 K to 229.9 K (-0.09 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.83 | 1,935 | 88,681 | 230,145 | 232.1 K to 230.1 K (-0.83 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.83 | 100 | 4,583 | 232,080 | 232.2 K to 232.1 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.83 | 800 | 36,660 | 232,180 | 233 K to 232.2 K (-0.34 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.82 | 3,900 | 178,698 | 232,980 | 236.9 K to 233 K (-1.65 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.82 | 100 | 4,582 | 236,880 | 237 K to 236.9 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.82 | 500 | 22,908 | 236,980 | 237.5 K to 237 K (-0.21 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.81 | 4,300 | 196,983 | 237,480 | 241.8 K to 237.5 K (-1.78 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.81 | 400 | 18,323 | 241,780 | 242.2 K to 241.8 K (-0.17 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.81 | 900 | 41,225 | 242,180 | 243.1 K to 242.2 K (-0.37 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.80 | 1,373 | 62,883 | 243,080 | 244.5 K to 243.1 K (-0.56 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.80 | 100 | 4,580 | 244,453 | 244.6 K to 244.5 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.80 | 1,800 | 82,431 | 244,553 | 246.4 K to 244.6 K (-0.73 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.79 | 400 | 18,316 | 246,353 | 246.8 K to 246.4 K (-0.16 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.79 | 200 | 9,158 | 246,753 | 247 K to 246.8 K (-0.08 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.79 | 1,100 | 50,364 | 246,953 | 248.1 K to 247 K (-0.44 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.78 | 1,600 | 73,248 | 248,053 | 249.7 K to 248.1 K (-0.64 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.78 | 100 | 4,578 | 249,653 | 249.8 K to 249.7 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.78 | 2,400 | 109,860 | 249,753 | 252.2 K to 249.8 K (-0.95 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.77 | 4,000 | 183,080 | 252,153 | 256.2 K to 252.2 K (-1.56 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.77 | 100 | 4,577 | 256,153 | 256.3 K to 256.2 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.77 | 3,016 | 138,027 | 256,253 | 259.3 K to 256.3 K (-1.16 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.76 | 1,384 | 63,332 | 259,269 | 260.7 K to 259.3 K (-0.53 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.76 | 200 | 9,152 | 260,653 | 260.9 K to 260.7 K (-0.08 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.76 | 400 | 18,302 | 260,853 | 261.3 K to 260.9 K (-0.15 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.75 | 900 | 41,175 | 261,253 | 262.2 K to 261.3 K (-0.34 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.75 | 300 | 13,724 | 262,153 | 262.5 K to 262.2 K (-0.11 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.74 | 2,900 | 132,646 | 262,453 | 265.4 K to 262.5 K (-1.09 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.74 | 700 | 32,015 | 265,353 | 266.1 K to 265.4 K (-0.26 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.73 | 5,000 | 228,650 | 266,053 | 271.1 K to 266.1 K (-1.84 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.73 | 100 | 4,573 | 271,053 | 271.2 K to 271.1 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.73 | 1,300 | 59,443 | 271,153 | 272.5 K to 271.2 K (-0.48 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.72 | 2,300 | 105,156 | 272,453 | 274.8 K to 272.5 K (-0.84 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.72 | 100 | 4,572 | 274,753 | 274.9 K to 274.8 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.72 | 800 | 36,572 | 274,853 | 275.7 K to 274.9 K (-0.29 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 25.25 | 83,000 | 2,095,426 | 0 | |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.71 | 2,500 | 114,275 | 275,653 | 278.2 K to 275.7 K (-0.90 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.71 | 600 | 27,423 | 278,153 | 278.8 K to 278.2 K (-0.22 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.70 | 2,500 | 114,250 | 278,753 | 281.3 K to 278.8 K (-0.89 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.70 | 100 | 4,570 | 281,253 | 281.4 K to 281.3 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.69 | 2,600 | 118,794 | 281,353 | 284 K to 281.4 K (-0.92 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.69 | 100 | 4,569 | 283,953 | 284.1 K to 284 K (-0.04 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.69 | 600 | 27,411 | 284,053 | 284.7 K to 284.1 K (-0.21 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.68 | 2,700 | 123,336 | 284,653 | 287.4 K to 284.7 K (-0.94 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.68 | 100 | 4,568 | 287,353 | 287.5 K to 287.4 K (-0.03 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.68 | 900 | 41,108 | 287,453 | 288.4 K to 287.5 K (-0.31 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.67 | 2,500 | 114,175 | 288,353 | 290.9 K to 288.4 K (-0.86 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.67 | 700 | 31,966 | 290,853 | 291.6 K to 290.9 K (-0.24 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.66 | 3,987 | 182,046 | 291,553 | 295.5 K to 291.6 K (-1.35 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.66 | 100 | 4,566 | 295,540 | 295.6 K to 295.5 K (-0.03 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.66 | 500 | 22,828 | 295,640 | 296.1 K to 295.6 K (-0.17 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.65 | 2,700 | 123,255 | 296,140 | 298.8 K to 296.1 K (-0.90 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.65 | 200 | 9,129 | 298,840 | 299 K to 298.8 K (-0.07 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.64 | 1,700 | 77,588 | 299,040 | 300.7 K to 299 K (-0.57 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.63 | 700 | 31,941 | 300,740 | 301.4 K to 300.7 K (-0.23 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.63 | 300 | 13,688 | 301,440 | 301.7 K to 301.4 K (-0.10 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.62 | 805 | 36,724 | 301,740 | 302.5 K to 301.7 K (-0.27 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.61 | 1,300 | 59,293 | 302,545 | 303.8 K to 302.5 K (-0.43 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.61 | 400 | 18,242 | 303,845 | 304.2 K to 303.8 K (-0.13 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.60 | 2,300 | 104,880 | 304,245 | 306.5 K to 304.2 K (-0.75 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.60 | 200 | 9,119 | 306,545 | 306.7 K to 306.5 K (-0.07 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.59 | 1,600 | 72,944 | 306,745 | 308.3 K to 306.7 K (-0.52 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.58 | 1,400 | 63,812 | 308,345 | 309.7 K to 308.3 K (-0.45 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.58 | 100 | 4,558 | 309,745 | 309.8 K to 309.7 K (-0.03 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 45.57 | 100 | 4,557 | 309,845 | 309.9 K to 309.8 K (-0.03 %) |
Feb 06 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 25.25 | 83,000 | 2,095,426 | 309,945 | 226.9 K to 309.9 K (+36.57 %) |
Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 39.79 | 13,263 | 527,735 | 226,945 | 240.2 K to 226.9 K (-5.52 %) |
Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 39.12 | 141,478 | 5,534,619 | 141,478 | |
Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 23,109 | 0 | 240,208 | 217.1 K to 240.2 K (+10.64 %) |
Mar 01 2013 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 34.26 | 15,105 | 517,497 | 217,099 | 232.2 K to 217.1 K (-6.51 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 34.94 | 149,600 | 5,227,024 | 149,600 | |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 35.08 | 12,147 | 426,117 | 232,204 | 244.4 K to 232.2 K (-4.97 %) |
Feb 20 2013 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 28,800 | 0 | 244,351 | 215.6 K to 244.4 K (+13.36 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 41.92 | 100,000 | 4,192,000 | 0 | |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.40 | 12,840 | 737,016 | 215,551 | 228.4 K to 215.6 K (-5.62 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.40 | 2,400 | 137,748 | 228,391 | 230.8 K to 228.4 K (-1.04 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.39 | 16,005 | 918,527 | 230,791 | 246.8 K to 230.8 K (-6.49 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.39 | 200 | 11,478 | 246,796 | 247 K to 246.8 K (-0.08 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.39 | 1,773 | 101,744 | 246,996 | 248.8 K to 247 K (-0.71 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.38 | 10,327 | 592,563 | 248,769 | 259.1 K to 248.8 K (-3.99 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.38 | 2,700 | 154,913 | 259,096 | 261.8 K to 259.1 K (-1.03 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.37 | 12,700 | 728,599 | 261,796 | 274.5 K to 261.8 K (-4.63 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.37 | 100 | 5,737 | 274,496 | 274.6 K to 274.5 K (-0.04 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.37 | 100 | 5,737 | 274,596 | 274.7 K to 274.6 K (-0.04 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.37 | 1,000 | 57,365 | 274,696 | 275.7 K to 274.7 K (-0.36 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.36 | 8,800 | 504,768 | 275,696 | 284.5 K to 275.7 K (-3.09 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.36 | 100 | 5,736 | 284,496 | 284.6 K to 284.5 K (-0.04 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.36 | 1,600 | 91,768 | 284,596 | 286.2 K to 284.6 K (-0.56 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.35 | 6,800 | 389,980 | 286,196 | 293 K to 286.2 K (-2.32 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.35 | 500 | 28,673 | 292,996 | 293.5 K to 293 K (-0.17 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.34 | 4,200 | 240,828 | 293,496 | 297.7 K to 293.5 K (-1.41 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.34 | 1,300 | 74,536 | 297,696 | 299 K to 297.7 K (-0.43 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.33 | 6,900 | 395,577 | 298,996 | 305.9 K to 299 K (-2.26 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.33 | 200 | 11,465 | 305,896 | 306.1 K to 305.9 K (-0.07 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.32 | 6,055 | 347,073 | 306,096 | 312.2 K to 306.1 K (-1.94 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.32 | 400 | 22,926 | 312,151 | 312.6 K to 312.2 K (-0.13 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 57.31 | 3,000 | 171,930 | 312,551 | 315.6 K to 312.6 K (-0.95 %) |
Mar 07 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 41.92 | 100,000 | 4,192,000 | 315,551 | 215.6 K to 315.6 K (+46.39 %) |
Mar 02 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 57.04 | 14,884 | 848,983 | 215,551 | 230.4 K to 215.6 K (-6.46 %) |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 56.26 | 52,300 | 2,942,398 | 52,300 | |
Feb 22 2012 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 28,900 | 0 | 230,435 | 201.5 K to 230.4 K (+14.34 %) |
Mar 02 2011 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 47.64 | 13,100 | 624,084 | 201,535 | 214.6 K to 201.5 K (-6.10 %) |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 46.60 | 50,100 | 2,334,660 | 50,100 | |
Feb 23 2011 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 35,600 | 0 | 214,635 | 179 K to 214.6 K (+19.88 %) |
Aug 03 2010 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 49.08 | 2,289 | 112,344 | 179,035 | 181.3 K to 179 K (-1.26 %) |
Mar 02 2010 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 54.12 | 11,731 | 634,882 | 181,324 | 193.1 K to 181.3 K (-6.08 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 54.50 | 46,900 | 2,556,050 | 46,900 | |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 32,000 | 0 | 193,055 | 161.1 K to 193.1 K (+19.87 %) |
Feb 23 2010 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 32,000 | 0 | 161,055 | 129.1 K to 161.1 K (+24.80 %) |
Feb 18 2010 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 53.93 | 5,041 | 271,861 | 129,055 | 134.1 K to 129.1 K (-3.76 %) |
Apr 22 2009 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 44.09 | 3,946 | 173,979 | 134,096 | 138 K to 134.1 K (-2.86 %) |
Mar 03 2009 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 50.58 | 5,127 | 259,324 | 138,042 | 143.2 K to 138 K (-3.58 %) |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 54.14 | 64,900 | 3,513,686 | 64,900 | |
Feb 24 2009 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 45,800 | 0 | 143,169 | 97.4 K to 143.2 K (+47.04 %) |
Mar 04 2008 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 54.22 | 2,431 | 131,809 | 97,369 | 99.8 K to 97.4 K (-2.44 %) |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 55.56 | 93,400 | 5,189,304 | 93,400 | |
Feb 20 2008 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 55.56 | 23,000 | 1,277,880 | 99,800 | 76.8 K to 99.8 K (+29.95 %) |
Aug 02 2007 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 50.74 | 22,000 | 1,116,280 | 22,000 | |
Aug 02 2007 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 50.74 | 4,000 | 202,960 | 76,800 | 72.8 K to 76.8 K (+5.49 %) |
Aug 02 2007 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 50.74 | 5,400 | 273,996 | 72,800 | 67.4 K to 72.8 K (+8.01 %) |
Feb 20 2007 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Senior Vice Preside ... | Option Exercise | A | 52.54 | 83,000 | 4,360,820 | 83,000 | |
Feb 20 2007 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Senior Vice Preside ... | Grant | A | 52.54 | 17,000 | 893,180 | 67,400 | 50.4 K to 67.4 K (+33.73 %) |
Feb 20 2007 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Senior Vice Preside ... | Grant | A | 52.54 | 20,400 | 1,071,816 | 50,400 | 30 K to 50.4 K (+68.00 %) |
Page: 1